关注
Michael Bogenschutz
Michael Bogenschutz
NYU School of Medicine
在 nyulangone.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study
MP Bogenschutz, AA Forcehimes, JA Pommy, CE Wilcox, PCR Barbosa, ...
Journal of psychopharmacology 29 (3), 289-299, 2015
9992015
Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum
CM Wilson, AE Serrano, A Wasley, MP Bogenschutz, AH Shankar, ...
Science 244 (4909), 1184-1186, 1989
5851989
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
JM Mitchell, M Bogenschutz, A Lilienstein, C Harrison, S Kleiman, ...
Focus 21 (3), 315-328, 2023
4202023
Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial
GE Woody, SA Poole, G Subramaniam, K Dugosh, M Bogenschutz, ...
Jama 300 (17), 2003-2011, 2008
3942008
Sacred knowledge: Psychedelics and religious experiences
WA Richards
Columbia University Press, 2015
2512015
Classic hallucinogens in the treatment of addictions
MP Bogenschutz, MW Johnson
Progress in Neuro-Psychopharmacology and Biological Psychiatry 64, 250-258, 2016
2502016
Olanzapine versus placebo in the treatment of borderline personality disorder
MP Bogenschutz, HG Nurnberg
Journal of Clinical Psychiatry 65 (1), 104-109, 2004
2332004
Development of a bibliography on religion, spirituality and addictions
C Geppert, MP Bogenschutz, WR Miller
Drug and alcohol review 26 (4), 389-395, 2007
1972007
Adolescent substance abuse: the effects of alcohol and marijuana on neuropsychological performance
RJ Thoma, MA Monnig, PA Lysne, DA Ruhl, JA Pommy, M Bogenschutz, ...
Alcoholism: Clinical and Experimental Research 35 (1), 39-46, 2011
1802011
Cognitive control in alcohol use disorder: deficits and clinical relevance
CE Wilcox, CJ Dekonenko, AR Mayer, MP Bogenschutz, JA Turner
Reviews in the Neurosciences 25 (1), 1-24, 2014
1612014
Health status of ayahuasca users
PCR Barbosa, S Mizumoto, MP Bogenschutz, RJ Strassman
Drug testing and analysis 4 (7-8), 601-609, 2012
1442012
Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial
MP Bogenschutz, S Ross, S Bhatt, T Baron, AA Forcehimes, E Laska, ...
JAMA psychiatry 79 (10), 953-962, 2022
1292022
Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trial
MP Bogenschutz, DM Donovan, RN Mandler, HI Perl, AA Forcehimes, ...
JAMA internal medicine 174 (11), 1736-1745, 2014
1232014
Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses
MP Bogenschutz, JM Pommy
Drug testing and analysis 4 (7-8), 543-555, 2012
1142012
Pharmacotherapy for pregnant women with addictions
WF Rayburn, MP Bogenschutz
American Journal of Obstetrics and Gynecology 191 (6), 1885-1897, 2004
1032004
Therapeutic applications of classic hallucinogens
MP Bogenschutz, S Ross
Behavioral neurobiology of psychedelic drugs, 361-391, 2018
982018
Psychological and neuropsychological assessment of regular hoasca users
PCR Barbosa, RJ Strassman, DX Da Silveira, K Areco, R Hoy, J Pommy, ...
Comprehensive psychiatry 71, 95-105, 2016
982016
Examining an affect regulation model of substance abuse in schizophrenia: the role of traits and coping
JJ Blanchard, D Squires, T Henry, WP Horan, M Bogenschutz, J Lauriello, ...
The Journal of nervous and mental disease 187 (2), 72-79, 1999
941999
Spirituality and addiction
WR Miller, MP Bogenschutz
Southern Medical Journal 100 (4), 433-437, 2007
932007
Clinical interpretations of patient experience in a trial of psilocybin-assisted psychotherapy for alcohol use disorder
MP Bogenschutz, SK Podrebarac, JH Duane, SS Amegadzie, TC Malone, ...
Frontiers in pharmacology 9, 100, 2018
902018
系统目前无法执行此操作,请稍后再试。
文章 1–20